Brief: Citius Pharmaceuticals Announces 1-For-25 Reverse Stock Split
22/11/2024 14:17
Nov 22 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS, INC. ANNOUNCES 1-FOR-25 REVERSE
STOCK
SPLIT
* CITIUS PHARMACEUTICALS INC - REVERSE STOCK SPLIT EFFECTIVE
AT
5:00 PM ET ON NOV 25, 2024
* CITIUS PHARMACEUTICALS INC - REVERSE STOCK SPLIT INTENDED
TO
REGAIN NASDAQ COMPLIANCE
Source text: ID:nPn43SHZSa
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules